Requirements for Medicines Registration in the Americas
MetadataShow full item record
This document comprises the requirements for the initial registration of medicines (marketing authorization) in the Americas, prepared by the Working Group on Medicines Registration of the Pan American Network on Drug Regulatory Harmonization (PANDRH). Its purpose is to provide requirements for establishing regulations and regulatory tools that will contribute to the harmonization process of medicines registration to ensuring the efficacy, quality and safety of medicines to be available in the countries of our Region.
Requisitos para el registro de medicamentos en las Américas
Showing items related by title, author, creator and subject.
Cassiani, Silvia Helena De Bortoli; Lecorps, Kimberly; Rojas Cañaveral, Luz Karina; da Silva, Fernando A Menezes; Fitzgerald, James (2020-08)[ABSTRACT]. Objective. To describe and analyze the current nursing regulations across countries in the Region of the Americas. Methods. A country comparative analysis was carried out by gathering information from the ...
Lietzan, Erika (2017-09)Dear editor I write in response to an article published in January 2016 regarding Colombia’s 2014 regulation governing registration of biosimilar biological products (1). In my view, the article seriously misstates ...
Rodríguez-Feria, Pablo; Cuervo, Luis Gabriel (2017-02)This descriptive study identifies trends in clinical trial registration in the World Health Organization International Clinical Trial Registry Platform (ICTRP) for Latin America and the Caribbean (LAC), from 2007–2013, ...